Page last updated: 2024-08-25

rosiglitazone and 15-deoxyprostaglandin j2

rosiglitazone has been researched along with 15-deoxyprostaglandin j2 in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	29 (69.05)	29.6817
2010's	13 (30.95)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elstner, E; Fenner, MH; Liu, H; Possinger, K; Zang, C	1
Evers, BM; Farrow, B; Hashimoto, K; Iwamura, T; O'Connor, KL	1
Brossart, P; Denzlinger, C; Grünebach, F; Lauber, K; Nencioni, A; Van Parijs, L; Wesselborg, S	1
Bonacci, JV; Gould, H; Harris, T; Stewart, AG; Ward, JE	1
Akbiyik, F; Blumberg, N; Francis, CW; Gettings, KF; Phipps, RP; Ray, DM	1
Bängeroth, K; Elstner, E; Eucker, J; Heider, U; Jakob, C; Krebbel, H; Possinger, K; Sezer, O; Zang, C; Zavrski, I	1
Chen, J; Chen, Q; Jiang, H; Shen, J; Shen, X; Sun, T	1
Burgess, HA; Daugherty, LE; Lakatos, HF; Phipps, RP; Ray, DM; Redonnet, M; Sime, PJ; Thatcher, TH	1
Etoh, K; Fujieda, H; Hattori, Y; Imagawa, M; Kohda, K; Miyata, N; Nakagawa, H; Nishizuka, M; Suzuki, T; Usui, S	1
Hart, CM; Mazzella, LJ; Polikandriotis, JA; Rupnow, HL	1
Amiri, F; Benkirane, K; Diep, QN; El Mabrouk, M; Schiffrin, EL	1
Bai, X; Chen, WC; Lin, MS	1
Chen, JJ; Cheung, WM; Lin, H; Lin, TN; Liou, JY; Shyue, SK; Wu, JS; Wu, KK	1
Coyle, AT; Kinsella, BT	1
Cuzzocrea, S	1
Chen, K; Ding, H; Jiang, H; Luo, H; Shen, X; Sun, T; Ye, F	1
Fernández, PL	1
Chadburn, A; Csernus, B; Hyjek, E; Jo, SH; Liu, Y; Wang, YL; Yang, C	1
Evain-Brion, D; Fournier, T; Handschuh, K; Tsatsaris, V	1
Authier, H; Auwerx, J; Balard, P; Benoit-Vical, F; Berry, A; Chambon, P; Coste, A; Desvergne, B; Lagane, C; Lepert, JC; Magnaval, JF; Metzger, D; Olagnier, D; Pipy, B; Séguéla, JP; Wahli, W	1
Barrera, G; Briatore, F; Cerbone, A; Dianzani, MU; Ferretti, C; Laurora, S; Pizzimenti, S; Toaldo, C	1
Alou, L; Caso, JR; Colón, A; Cos, E; Gómez-Lus, ML; Leza, JC; Lizasoain, I; Lorenzo, P; Menchén, L; Menchén, P; Moro, MA; Ponferrada, A; Sevillano, D	1
Fu, WM; Lin, CP; Lin, TH; Tang, CH; Yang, RS	1
Jang, SK; Kim, JH; Kim, WJ	1
Blanchard, J; Eismann, T; Galloway, E; Huber, N; Kuboki, S; Lentsch, AB; Schuster, R; Shin, T; Zingarelli, B	1
Baek, SJ; Cekanova, M; Kim, K; Li, X; Yuan, JS	1
Dong, YW; Wang, XP; Wu, K	1
Baglole, CJ; Ferguson, HE; Garcia-Bates, TM; Kottmann, RM; Olsen, KC; Phipps, RP; Sime, PJ; Strong, ER; Thatcher, TH	1
Li, H; Pauza, CD	1
Abdel-Aleem, OS; Badr, MZ; Donahue, RR; McNamara, KC; Morgenweck, J; Taylor, BK	1
Barrera, G; Cerbone, A; Daniela, B; Dianzani, MU; Ferretti, C; Giglioni, B; Menegatti, E; Minelli, R; Pettazzoni, P; Pizzimenti, S; Toaldo, C	1
Atherton, RE; Gibbins, JM; Jones, CI; Kaiser, WJ; Moraes, LA; Sage, T; Spyridon, M	1
Chen, C; Chen, X; Du, H; Zhang, J	1
Amoruso, A; Balbo, P; Bardelli, C; Brunelleschi, S; Celi, A; Federici Canova, D; Fresu, L; Neri, T	1
Alves, CF; Carregaro, V; Cheraim, AB; Cunha, FQ; da Silva, CA; de Oliveira, JR; Farnesi-de-Assunção, TS; Napimoga, MH	1
Chen, XF; Dong, L; Lin, J; Wan, CJ	1
Li, J; Liu, L; Liu, Y; Sun, J; Xia, S; Xu, D; Xu, Y; Yang, Z; Zhang, L; Zou, F	1
Bogacka, I; Bogacki, M; Chojnowska, K; Kurzyńska, A	1
Dong, X; Gao, D; Hao, G; Liu, Z; Meng, Z; Ning, N; Niu, X; Yang, G	1
Ennis, WJ; Fang, MM; Koh, TJ; Mirza, RE; Novak, ML; Sui, A; Urao, N	1
Huxlin, KR; Jeon, KI; Phipps, RP; Sime, PJ	1
Bai, M; Chen, Y; Ding, G; Huang, S; Jia, Z; Xu, Y; Zhang, A; Zhang, Y; Zhao, M	1

Reviews

1 review(s) available for rosiglitazone and 15-deoxyprostaglandin j2

Article	Year
Peroxisome proliferator-activated receptors and acute lung injury. Current opinion in pharmacology, 2006, Volume: 6, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Humans; Ligands; PPAR alpha; PPAR gamma; Prostaglandin D2; Respiratory Distress Syndrome; Rosiglitazone; Thiazolidinediones	2006

Other Studies

41 other study(ies) available for rosiglitazone and 15-deoxyprostaglandin j2

Article	Year
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. Breast cancer research and treatment, 2003, Volume: 79, Issue:1 Topics: Breast Neoplasms; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Nuclear Proteins; Pioglitazone; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Tissue Inhibitor of Metalloproteinases; Transcription Factors; Tretinoin; Tumor Cells, Cultured	2003
Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator. Surgery, 2003, Volume: 134, Issue:2 Topics: Chromans; Humans; Integrins; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Pancreatic Neoplasms; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Tissue Plasminogen Activator; Transcription Factors; Troglitazone; Tumor Cells, Cultured	2003
Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. Journal of immunology (Baltimore, Md. : 1950), 2003, Nov-15, Volume: 171, Issue:10 Topics: Apoptosis; Cyclopentanes; Down-Regulation; Growth Inhibitors; Humans; Intracellular Membranes; Jurkat Cells; Lymphocyte Activation; Membrane Potentials; Mitochondria; Oxidative Stress; Permeability; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Rosiglitazone; Signal Transduction; T-Lymphocyte Subsets; Thiazolidinediones; Transcription Factors	2003
PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. British journal of pharmacology, 2004, Volume: 141, Issue:3 Topics: Bronchi; Cell Count; Cell Division; Cells, Cultured; Humans; Ligands; Muscle, Smooth; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors	2004
Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood, 2004, Sep-01, Volume: 104, Issue:5 Topics: Adenosine Triphosphate; Blood Platelets; Bone Marrow Cells; CD40 Ligand; Cell Line; DNA-Binding Proteins; Gene Expression; Humans; Hypoglycemic Agents; Megakaryocytes; Platelet Aggregation; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Thromboxane B2; Transcription Factors	2004
Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma. Anti-cancer drugs, 2004, Volume: 15, Issue:10 Topics: Apoptosis; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Humans; Ligands; Multiple Myeloma; Pioglitazone; PPAR gamma; Prostaglandin D2; Rosiglitazone; Thiazolidinediones	2004
A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. Analytical biochemistry, 2004, Dec-15, Volume: 335, Issue:2 Topics: alpha-Galactosidase; Anilides; Cells, Cultured; Chromans; CREB-Binding Protein; Drug Evaluation, Preclinical; Genes, Reporter; Indomethacin; Ligands; Nuclear Proteins; Oxazoles; Pioglitazone; PPAR gamma; Prostaglandin D2; Protein Binding; Rosiglitazone; Thiazolidinediones; Trans-Activators; Troglitazone; Two-Hybrid System Techniques; Tyrosine; Yeasts	2004
PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. American journal of physiology. Lung cellular and molecular physiology, 2005, Volume: 288, Issue:6 Topics: Actins; Anilides; Cell Differentiation; Collagen Type I; Fibroblasts; Humans; Hypoglycemic Agents; Lung; Muscle, Smooth; PPAR gamma; Prostaglandin D2; Pulmonary Fibrosis; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta	2005
Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2. Bioorganic & medicinal chemistry letters, 2005, Mar-15, Volume: 15, Issue:6 Topics: Adipocytes; Animals; Cells, Cultured; Drug Design; Ligands; Models, Molecular; Molecular Structure; PPAR gamma; Prostaglandin D2; Protein Binding; Rats; Rosiglitazone; Thiazolidinediones	2005
Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms. Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:9 Topics: Anilides; Cells, Cultured; Endothelium, Vascular; Genes, Reporter; Humans; Hypoglycemic Agents; Ligands; Nitric Oxide; PPAR gamma; Prostaglandin D2; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Umbilical Veins	2005
PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Carrier Proteins; Cell Proliferation; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phosphoproteins; Phosphoric Monoester Hydrolases; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Rosiglitazone; Signal Transduction; Thiazolidinediones; Thymidine	2006
Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor gamma activation up-regulating PTEN and inhibiting PI3K activity. Chinese medical journal, 2005, Sep-05, Volume: 118, Issue:17 Topics: Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; HT29 Cells; Humans; Phosphoinositide-3 Kinase Inhibitors; Phosphoric Monoester Hydrolases; PPAR gamma; Prostaglandin D2; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rosiglitazone; Thiazolidinediones; Tumor Suppressor Proteins; Up-Regulation	2005
15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:3 Topics: Adenoviridae; Animals; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Cyclooxygenase 1; Gene Transfer Techniques; Genetic Therapy; Heme Oxygenase-1; Infarction, Middle Cerebral Artery; Male; Necrosis; Neurons; Neuroprotective Agents; PPAR gamma; Prostaglandin D2; Rats; Rats, Long-Evans; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Vasodilator Agents	2006
Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells. Biochemical pharmacology, 2006, Apr-28, Volume: 71, Issue:9 Topics: Cell Line; Cell Line, Tumor; Chromans; Genes, Reporter; Humans; Leukemia, Erythroblastic, Acute; Luciferases; PPAR gamma; Promoter Regions, Genetic; Prostaglandin D2; Protein Isoforms; Receptors, Thromboxane A2, Prostaglandin H2; Retinoid X Receptor alpha; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factor AP-1; Transcription, Genetic; Troglitazone	2006
Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2006, Volume: 18, Issue:1-3 Topics: Anilides; Animals; Biological Transport; Blotting, Western; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Green Fluorescent Proteins; Microscopy, Fluorescence; Models, Biological; PPAR gamma; Prostaglandin D2; Recombinant Fusion Proteins; Rosiglitazone; Signal Transduction; Smad2 Protein; Thiazolidinediones; Transfection; Transforming Growth Factor beta	2006
[Stress and inflammatory bowell disease (I.B.D). Therapeutic strategies]. Anales de la Real Academia Nacional de Medicina, 2006, Volume: 123, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Translocation; Colitis, Ulcerative; Disease Models, Animal; Humans; Immobilization; Immunoglobulin A; Inflammatory Bowel Diseases; PPAR gamma; Prostaglandin D2; Prostaglandins; Rats; Rosiglitazone; Stress, Psychological; Thiazolidinediones; Time Factors	2006
Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. The American journal of pathology, 2007, Volume: 170, Issue:2 Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Fatty Acids; Glucose; Humans; Hypoglycemic Agents; Ligands; Lymphoma, T-Cell; Membrane Potential, Mitochondrial; Mitochondria; Neoplasm Proteins; Peroxisome Proliferators; PPAR gamma; Prostaglandin D2; Pyrimidines; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones	2007
Involvement of PPARgamma in human trophoblast invasion. Placenta, 2007, Volume: 28 Suppl A Topics: Cell Movement; Female; Humans; Ligands; Lipoproteins, LDL; Maternal-Fetal Exchange; Placenta; PPAR gamma; Pregnancy; Pregnancy Trimester, First; Prostaglandin D2; Retinoid X Receptor alpha; Rosiglitazone; Scavenger Receptors, Class E; Thiazolidinediones; Trophoblasts	2007
IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. European journal of immunology, 2007, Volume: 37, Issue:6 Topics: Anilides; Animals; Arachidonic Acids; CD36 Antigens; Cell Line, Tumor; DNA; Enzyme Inhibitors; Erythrocytes; Gene Expression; Humans; Hypoglycemic Agents; Interleukin-13; Macrophages; Macrophages, Peritoneal; Mice; Monocytes; Organophosphonates; Phagocytosis; Phospholipases A; Phospholipases A2; Plasmodium falciparum; PPAR gamma; Prostaglandin D2; Protein Binding; Rosiglitazone; Thiazolidinediones; Transfection	2007
4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells. Free radical biology & medicine, 2007, Jun-01, Volume: 42, Issue:11 Topics: Aldehydes; Apoptosis; bcl-2-Associated X Protein; Caco-2 Cells; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Cross-Linking Reagents; Cysteine Proteinase Inhibitors; Drug Synergism; Gene Expression; Humans; Ligands; PPAR gamma; Prostaglandin D2; Rosiglitazone; Thiazolidinediones	2007
The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. Gastroenterology, 2007, Volume: 132, Issue:5 Topics: Animals; Bacterial Translocation; Benzamides; Colitis; Colon; Corticosterone; Cyclooxygenase 2; Gene Expression Regulation, Enzymologic; Homeostasis; Intestinal Absorption; Ligands; Male; Nitric Oxide Synthase Type II; Peroxidase; PPAR gamma; Prostaglandin D2; Pyridines; Rats; Rats, Wistar; Restraint, Physical; Rosiglitazone; Stress, Physiological; Thiazolidinediones	2007
PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. Bone, 2007, Volume: 41, Issue:4 Topics: Aging; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Down-Regulation; Gene Expression Regulation, Enzymologic; Ligands; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoblasts; Osteogenesis; PPAR gamma; Prostaglandin D2; Rats; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors; Transforming Growth Factor beta	2007
Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. The EMBO journal, 2007, Dec-12, Volume: 26, Issue:24 Topics: Anti-Inflammatory Agents; Arachidonic Acid; Arsenites; Chromans; Cyclopentanes; Cytoplasmic Granules; Dinoprostone; Emetine; Enzyme Inhibitors; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4A; Gene Expression Regulation; HeLa Cells; Humans; Hypoglycemic Agents; Inflammation; Poly(A)-Binding Proteins; PPAR gamma; Prostaglandin D2; Prostaglandins A; Protein Biosynthesis; Protein Synthesis Inhibitors; Rosiglitazone; Signal Transduction; Sodium Compounds; T-Cell Intracellular Antigen-1; Thiazolidinediones; TNF Receptor-Associated Factor 2; Troglitazone; Tumor Necrosis Factor-alpha	2007
Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:1 Topics: Animals; C-Peptide; E1A-Associated p300 Protein; Gene Expression Regulation; Hepatocytes; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Prostaglandin D2; Reperfusion Injury; Retinoid X Receptor alpha; Rosiglitazone; Thiazolidinediones	2008
Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells. International journal of oncology, 2008, Volume: 32, Issue:4 Topics: Colorectal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; PPAR gamma; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcriptional Activation	2008
Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition. World journal of gastroenterology, 2009, Jan-28, Volume: 15, Issue:4 Topics: Animals; Base Sequence; Cell Line, Tumor; Female; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Pancreatic Neoplasms; PPAR gamma; Prostaglandin D2; Retinoid X Receptor alpha; RNA, Messenger; RNA, Neoplasm; Rosiglitazone; Thiazolidinediones; Transplantation, Heterologous; Tretinoin; Vascular Endothelial Growth Factor A	2009
Peroxisome proliferator-activated receptor-gamma ligands induce heme oxygenase-1 in lung fibroblasts by a PPARgamma-independent, glutathione-dependent mechanism. American journal of physiology. Lung cellular and molecular physiology, 2009, Volume: 297, Issue:5 Topics: Acetylcysteine; Cell Differentiation; Cell Nucleus; Chromans; Dose-Response Relationship, Drug; Enzyme Induction; Fibroblasts; Glutathione; Heme Oxygenase-1; Humans; Ligands; Lung; NF-E2-Related Factor 2; Oleanolic Acid; PPAR gamma; Prostaglandin D2; Protein Transport; Rosiglitazone; Thiazolidinediones; Transcription Factor AP-1; Up-Regulation	2009
Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells. PloS one, 2009, Nov-04, Volume: 4, Issue:11 Topics: Animals; Autoimmune Diseases; Cell Line, Tumor; Cell Proliferation; Cytokines; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoglycemic Agents; Leukocytes, Mononuclear; Ligands; Prostaglandin D2; Receptors, Antigen, T-Cell, gamma-delta; Rosiglitazone; STAT5 Transcription Factor; T-Lymphocytes; Thiazolidinediones	2009
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. Neuropharmacology, 2010, Volume: 58, Issue:2 Topics: Anilides; Animals; Benzhydryl Compounds; Brain; Central Nervous System Agents; Disease Models, Animal; Edema; Epoxy Compounds; Gene Expression; Inflammation; Male; Pain; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord; Thiazolidinediones	2010
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells. Journal of cellular and molecular medicine, 2010, Volume: 14, Issue:6A Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blotting, Western; Caco-2 Cells; Colonic Neoplasms; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Ligands; PPAR gamma; Promoter Regions, Genetic; Prostaglandin D2; Protein Binding; Proto-Oncogene Proteins c-myc; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Telomerase; Thiazolidinediones	2010
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation. Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:3 Topics: Adaptor Proteins, Signal Transducing; Anilides; Animals; Blood Platelets; Calcium; Collagen; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; Ligands; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Phosphorylation; Platelet Aggregation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Membrane Glycoproteins; PPAR gamma; Prostaglandin D2; Protein-Tyrosine Kinases; Rosiglitazone; Signal Transduction; Spectrometry, Fluorescence; Syk Kinase; Thiazolidinediones; Thrombosis; Time Factors; Tyrosine	2010
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. British journal of pharmacology, 2011, Volume: 163, Issue:7 Topics: Anilides; Animals; Arachidonic Acids; Benzodioxoles; Biphenyl Compounds; Cannabinoid Receptor Modulators; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endocannabinoids; Excitatory Postsynaptic Potentials; Glycerides; Hippocampus; Inflammation; Interleukin-1beta; Lipopolysaccharides; Mice; Monoacylglycerol Lipases; Neurons; NF-kappa B; Phosphorylation; Piperidines; PPAR gamma; Prostaglandin D2; Receptor, Cannabinoid, CB1; Rosiglitazone; Signal Transduction; Synaptic Transmission; Thiazolidinediones	2011
Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands. British journal of pharmacology, 2012, Volume: 165, Issue:3 Topics: Cell-Derived Microparticles; Cells, Cultured; Humans; Interleukin-6; Ligands; Macrophages; Monocytes; NF-kappa B; PPAR gamma; Prostaglandin D2; Rosiglitazone; Superoxides; Thiazolidinediones; Tumor Necrosis Factor-alpha	2012
PPAR-γ agonists, mainly 15d-PGJ(2), reduce eosinophil recruitment following allergen challenge. Cellular immunology, 2012, Volume: 273, Issue:1 Topics: Allergens; Animals; Cell Movement; Cell Proliferation; Disease Models, Animal; Eosinophilia; Eosinophils; Flow Cytometry; Immunoglobulin E; Inflammation; Interleukins; Leukocyte Count; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR gamma; Prostaglandin D2; Rosiglitazone; Thiazolidinediones	2012
[PPARgamma agonists against respiratory syncytial virus infection in vitro study]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2011, Volume: 25, Issue:6 Topics: Cells, Cultured; Humans; PPAR gamma; Prostaglandin D2; Respiratory Syncytial Viruses; Rosiglitazone; Thiazolidinediones	2011
Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells. PloS one, 2013, Volume: 8, Issue:8 Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Glycoproteins; Humans; Liver Neoplasms; Male; Membrane Glycoproteins; Mice; Mice, Nude; NADPH Oxidase 2; NADPH Oxidases; Neoplastic Stem Cells; Oxidative Stress; Peptides; Phenotype; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Ribonucleosides; Rosiglitazone; Thiazolidinediones	2013
The involvement of peroxisome proliferator activated receptors (PPARs) in prostaglandin F2α production by porcine endometrium. Reproductive biology, 2013, Volume: 13, Issue:4 Topics: Analysis of Variance; Anilides; Animals; Benzamides; Culture Media; Dinoprost; DNA Primers; Endometrium; Estrous Cycle; Female; Indoles; Peroxisome Proliferator-Activated Receptors; Phenoxyacetates; Pregnancy; Prostaglandin D2; Pyridines; Pyrimidines; Radioimmunoassay; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Swine; Thiazolidinediones	2013
Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells. PloS one, 2015, Volume: 10, Issue:4 Topics: Angiotensin II; Anilides; Animals; Blood Pressure; Body Weight; Cell Proliferation; Cells, Cultured; Cyclin D1; Gene Expression Regulation; Hypoglycemic Agents; Kruppel-Like Transcription Factors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; PPAR gamma; Prostaglandin D2; Protein Kinase C; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones	2015
Macrophage PPARγ and impaired wound healing in type 2 diabetes. The Journal of pathology, 2015, Volume: 236, Issue:4 Topics: Administration, Cutaneous; Animals; Cells, Cultured; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Humans; Interleukin-1beta; Leg Ulcer; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Phenotype; PPAR gamma; Prostaglandin D2; Receptors, Interleukin-1 Type I; Rosiglitazone; Skin; Thiazolidinediones; Time Factors; Wound Healing	2015
Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts. Experimental eye research, 2015, Volume: 138 Topics: Actins; Animals; Blotting, Western; Cats; Cells, Cultured; Chromans; Collagen Type I; Connective Tissue Growth Factor; Corneal Keratocytes; Fibronectins; Hypoglycemic Agents; JNK Mitogen-Activated Protein Kinases; Ligands; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Prostaglandin D2; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta1; Troglitazone	2015
Renal tubular epithelium-targeted peroxisome proliferator-activated receptor-γ maintains the epithelial phenotype and antagonizes renal fibrogenesis. Oncotarget, 2016, Oct-04, Volume: 7, Issue:40 Topics: Animals; Cells, Cultured; Fibrosis; Humans; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Phenotype; PPAR gamma; Prostaglandin D2; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta1; Urothelium	2016